NASDAQ · Financial Statements
Oncolytics Biotech Inc. (ONCY) Financial Statements
$0.56
NASDAQ: ONCY
Market Cap $55.90M
Overview Financials Dividend Oncolytics Biotech Inc. most recently reported annual revenue of $0, net profit of $-29.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $0 $0 $0 $0 $0 Operating Profit $-26.0M $-20.0M $-25.0M $-26.0M $-29.0M Net Profit $-26.0M $-18.0M $-21.0M $-23.0M $-29.0M EPS $-0.49 $-0.44 $-0.41 $-0.30 $-0.41 Op Margin — — — — —
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $46.0M $37.0M $39.0M $20.0M $10.0M Total Liabilities $10.0M $11.0M $11.0M $14.0M $16.0M Cash $41.0M $12.0M $35.0M $16.0M $7.0M Borrowings $1.0M $0 $0 $1.0M $1.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-22.0M $-17.0M $-21.0M $-20.0M $-20.0M Investing Cash Flow $-1.0M $-15.0M $15.0M $0 $0 Financing Cash Flow $0 $0 $0 $0 $0 Net Cash Flow $10.0M $-22.0M $18.0M $-15.0M $-6.0M Free Cash Flow $-23.0M $-17.0M $-21.0M $-20.0M $-20.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.09 EV / EBITDA -2.05 FCF Yield -35.54% Quick Ratio 1.35 Interest Coverage 0.00 Return 1Y -19.12% Return 3Y -69.02% Return 5Y -61.44%
Screens featuring this stock